Session 7: Reviewing Clinical CVD Guidelines Through Clinical Cases - In Collaboration With the American Venous Forum (AVF)

Moderator(s)

• 

  Joseph Raffetto, MD

  Harvard Medical School
  Harvard Medical School
  Brighton, Massachusetts, United States
• 

  Mark Meissner, MD

  University of Washington School of Medicine
  University of Washington
  Seattle, Washington, United States

Presentations:

• 1:30 PM - 1:38 PM East Coast USA Time

  Venoactive Drugs and Treatment of Post-thrombotic Syndrome
  

  Speaker: Joseph Raffetto, MD
• 1:38 PM - 1:46 PM East Coast USA Time

  Classification of Pelvic Venous Disorders and Clinical Importance
  

  Speaker: Kathleen D. Gibson, MD
• 1:46 PM - 1:54 PM East Coast USA Time

  The State of the Art in Venous Stenting: Who Benefits and How to Assess Success?
  

  Speaker: Suresh Vedantham, MD
• 1:54 PM - 2:02 PM East Coast USA Time

  Which Patients with Venous Ulcers Benefit the Most from EVRA Recommendations?
  

  Speaker: Alun Davies, MA DM DSc FRCS FEBVS FFST FACPh FMedSci – Imperial
• 2:02 PM - 2:10 PM East Coast USA Time

  Are Certain Anticoagulants More Effective than Others for VTE?
  

  Speaker: Mark H. Meissner, MD
• 2:10 PM - 2:20 PM East Coast USA Time

  Discussion
  

  Panelist: Kathleen D. Gibson, MD

  Panelist: Suresh Vedantham, MD

  Panelist: Alun Davies, MA DM DSc FRCS FEBVS FFST FACPh FMedSci – Imperial